Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice

por Klimontov, Vadim V, Korbut, Anton I, Taskaeva, Iuliia S, Bgatova, Nataliya P, Dashkin, Maksim V, Orlov, Nikolai B, Khotskina, Anna S, Zavyalov, Evgenii L, Klein, Thomas
Publicado 2020

Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model

por Tsidulko, Alexandra Y., Shevelev, Oleg B., Khotskina, Anna S., Kolpakova, Mariia A., Suhovskih, Anastasia V., Kazanskaya, Galina M., Volkov, Alexander M., Aidagulova, Svetlana V., Zavyalov, Evgenii L., Grigorieva, Elvira V.
Publicado 2021

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes

por Korbut, Anton I., Taskaeva, Iuliia S., Bgatova, Nataliya P., Muraleva, Natalia A., Orlov, Nikolai B., Dashkin, Maksim V., Khotskina, Anna S., Zavyalov, Evgenii L., Konenkov, Vladimir I., Klein, Thomas, Klimontov, Vadim V.
Publicado 2020